Subscribe for great stories in your community!
Zelira Therapeutics, a biopharmaceutical company with operations in Plymouth Meeting and Australia, is preparing to launch clinical trials for its autism spectrum disorder drug in…
Conshohocken’s Madrigal Pharmaceuticals, saw third-quarter sales soar for its NASH treatment, Rezdiffra, writes John George for the Philadelphia Business Journal.
With revenue reaching…
Bimbo Bakeries USA, based in Horsham, has received a warning letter from the U.S. Food and Drug Administration indicating it has mislabeled its products…
Plymouth Meeting-based Harmony Biosciences received a green light from the Food and Drug Administration to widen the use of Wakix, its flagship narcolepsy drug…
The Food and Drug Administration has selected Bala Cynwyd-based Larimar Therapeutics’ lead drug candidate for its new program inspired by the Operation Warp Speed…
The Delaware County Health Department got a mention on John Oliver’s program “Last Week Tonight” Sunday night but officials weren’t exactly thrilled, writes…
Later this week, the U.S. Food and Drug Administration is expected to make a decision on Madrigal Pharmaceuticals’ experimental NASH treatment, writes John George…
Plymouth Meeting’s Inovio Pharmaceuticals is getting closer to seeking U.S. Food & Drug Administration approval for its first DNA medicine, writes John George…
Fort Washington’s Active Protective Technologies has received FDA breakthrough device designation for its Tango Belt, writes John George for the Philadelphia Business Journal.
Older…
University City-based Vitara Biomedical is currently working on an artificial womb for premature babies and is getting closer to human clinical trials, writes Liz…
After spending years advocating against the FDA-enacted restrictions that critics believe to be discriminatory against gay and bisexual men, Adam Joseph donated blood for…
A West Chester pharmaceutical company finally achieved federal approval of a new drug candidate that treats a contagious skin disease, writes John George for the…
During his 40 years at the Pennsylvania College of Optometry at Salus University in Elkins Park, Mitchell Scheiman, OD, PhD ‘16, FAAO, has worked for…
Braeburn, which is based in Plymouth Meeting, has received Food and Drug Administration marketing clearance for its opioid use disorder drug Brixadi four years after…
A QMED article cites data from ECRI, the Plymouth Meeting healthcare safety nonprofit, warning about a pervasive medical risk. QMED’s publication, MD+DI, had…
Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for its experimental non…
Collegeville resident Prem Ganesh, a senior bioengineering student at Temple, is back in on campus now. But he’s brought a summer’s worth of…
Philanthropists Susan and Steve Kelly, longtime supporters of the Children’s Hospital of Philadelphia (CHOP), are helping establish the Susan S. and Stephen P. Kelly…
Before we send you to this site, please subscribe to our daily newsletter.
